Issue
Med Sci (Paris)
Volume 39, Number 1, Janvier 2023
Maladies chroniques : transition de l’adolescence à l’âge adulte
Page(s) 58 - 63
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2022200
Published online 24 January 2023
  1. Registre français de la mucoviscidose : bilan des données 2020. https://www.vaincrelamuco.org/sites/default/files/rapporrt_annuel_2020_v3_0.pdf. [Google Scholar]
  2. Kerem E, Viviani L, Zolin A, et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J 2014 ; 43 : 125–133. [CrossRef] [PubMed] [Google Scholar]
  3. Quittner AL, Zhang J, Marynchenko M, et al. Pulmonary medication adherence and health-care use in cystic fibrosis. Chest 2014 ; 146 : 142–151. [CrossRef] [PubMed] [Google Scholar]
  4. Middleton PG, Mall MA, Drˇevínek P, et al. Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 2019 ; 381 : 1809–1819. [CrossRef] [PubMed] [Google Scholar]
  5. Protocole national de diagnostic et de soins pour la mucoviscidose (juillet 2017) https://www.has-sante.fr/upload/docs/application/pdf/2017-09/pnds_2017_vf1.pdf. [Google Scholar]
  6. Dumas A. Entre transition médicale et passage à l’âge adulte, un possible conflit de temporalité pour les jeunes atteints d’une maladie chronique. Med Sci (Paris) 2022; 38 : 70–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Gerardin P, Stheneur C. Maladie chronique : transition des services hospitaliers pour enfants et adolescents vers les services pour adultes : S’appuyer sur les enjeux de l’adolescence pour une transition réussie. Med Sci (Paris) 2021; 37 : 786–90. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  8. Welsh L, Robertson CF, Ranganathan SC. Increased rate of lung function decline in Australian adolescents with cystic fibrosis. Pediatr Pulmonol 2014 ; 49 : 873–877. [CrossRef] [PubMed] [Google Scholar]
  9. Okumura MJ, Ong T, Dawson D, et al. Improving transition from paediatric to adult cystic fibrosis care: programme implementation and evaluation. BMJ Qual Saf 2014 ; 23 Suppl 1: i64–i72. [CrossRef] [PubMed] [Google Scholar]
  10. Bourgeois G, Magne F, Nove Josserand R, et al. A formalized transition program for cystic fibrosis: A 10-year retrospective analysis of 97 patients in Lyon. Pediatr Pulmonol 2021; 56 : 2000–6. [CrossRef] [PubMed] [Google Scholar]
  11. West NE, Mogayzel PJ. Transitions in health care: What can we learn from our experience with cystic fibrosis. Pediatr Clin North Am 2016 ; 63 : 887–897. [CrossRef] [PubMed] [Google Scholar]
  12. Connett GJ, Nagra A. Ready, Steady, Go: Achieving successful transition in cystic fibrosis. Paediatr Respir Rev 2018 ; 27 : 13–15. [PubMed] [Google Scholar]
  13. Chaudhry SR, Keaton M, Nasr SZ. Evaluation of a cystic fibrosis transition program from pediatric to adult care. Pediatr Pulmonol 2013 ; 48 : 658–665. [CrossRef] [PubMed] [Google Scholar]
  14. Packel L, Sood M, Gormley M, et al. A pilot study exploring the role of physical therapists and transition in care of pediatric patients with cystic fibrosis to the adult setting. Cardiopulm Phys Ther J 2013 ; 24 : 24–30. [CrossRef] [PubMed] [Google Scholar]
  15. Huang JS, Terrones L, Tompane T, et al. Preparing adolescents with chronic disease for transition to adult care: a technology program. Pediatrics 2014 ; 133 : e1639–e1646. [CrossRef] [PubMed] [Google Scholar]
  16. Mellerio H, Jacquin P, Trelles N, et al. Validation of the Good2Go: the first French-language transition readiness questionnaire. Eur J Pediatr 2020; 179 : 61–71. [CrossRef] [PubMed] [Google Scholar]
  17. Elborn JS, Bell SC, Madge SL, et al. Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis. Eur Respir J 2016 ; 47 : 420–428. [CrossRef] [PubMed] [Google Scholar]
  18. August 3 ET, 2019. Transitioning from pediatric to adult cystic fibrosis care. Cystic-Fibrosis.com https://cystic-fibrosis.com/transition-adult-care. [Google Scholar]
  19. Brémont F, Mittaine M, Martin-Blondel A, et al. La mucoviscidose : transition de l’enfant à l’adulte. Arch Pediatr 2009 ; 16 : 581–582. [CrossRef] [PubMed] [Google Scholar]
  20. Murris-Espin M, Le Borgne A, Vignal G, et al. Transition enfant-adulte au cours de la mucoviscidose. Arch Pediatr 2016; 23 : 12S54–60. [CrossRef] [PubMed] [Google Scholar]
  21. Yankaskas JR, Marshall BC, Sufian B, et al. Cystic fibrosis adult care: consensus conference report. Chest 2004 ; 125 : 1S–39S. [CrossRef] [PubMed] [Google Scholar]
  22. Willis LD. Transition from pediatric to adult care for young adults with chronic respiratory disease. Respir Care 2020; 65 : 1916–22. [PubMed] [Google Scholar]
  23. Tuchman LK, Schwartz LA, Sawicki GS, et al. Cystic fibrosis and transition to adult medical care. Pediatrics 2010 ; 125 : 566–573. [CrossRef] [PubMed] [Google Scholar]
  24. Opoka-Winiarska V, Cofta S, Mazurek H, et al. Problems of patients with cystic fibrosis during transition to adulthood. Pneumonol Alergol Pol 2015 ; 83 : 394–400. [PubMed] [Google Scholar]
  25. Singh J, Towns S, Jayasuriya G, et al. Transition to adult care in cystic fibrosis: The challenges and the structure. Paediatr Respir Rev 2022; 41 : 23–9. [PubMed] [Google Scholar]
  26. Durieu I, Reynaud Q, Nove-Josserand R. Mucoviscidose : transition du centre pédiatrique au centre adulte. Rev Pneumol Clin 2016 ; 72 : 72–76. [CrossRef] [PubMed] [Google Scholar]
  27. Andersson M, Hedman L, Bjerg A, et al. Remission and persistence of asthma followed from 7 to 19 years of age. Pediatrics 2013 ; 132 : e435–e442. [CrossRef] [PubMed] [Google Scholar]
  28. Izadi N, Baraghoshi D, Curran-Everett D, et al. Factors associated with persistence of severe asthma from late adolescence to early adulthood. Am J Respir Crit Care Med 2021; 204(7) : 776–787. [CrossRef] [PubMed] [Google Scholar]
  29. Bitsko MJ, Everhart RS, Rubin BK. The adolescent with asthma. Paediatr Respir Rev 2014 ; 15 : 146–153. [PubMed] [Google Scholar]
  30. Roberts G, Vazquez-Ortiz M, Knibb R, et al. EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma. Allergy 2020; 75 : 2734–52. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.